A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Experimental Drug Gaining Traction Online
Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Commerce on Social Networks
Additionally, a robust trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in users injecting products of unknown origin.
Several professionals said the popularity for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Platform Response and Content Removal
Based on TikTok, the service has removed problematic content and banned related hashtags and search suggestions. The company stated it was dedicated to keeping the service secure and investing in enhancing compliance measures.
Online Marketplace Operations
Investigations also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.
Within moments of joining one community, a seller posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.
Item Information and Costs
Inside these groups, posts show dark colored packages with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A representative for the messaging service said it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service connected the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has previously encountered individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose patients to possibly significant medical dangers”.
